Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epaxal pediatric dose versus standard dose versus comparator hepatitis A vaccine in healthy children and adolescents
ISRCTN91009479Phase 3Completed
- Sponsor
- Berna Biotech AG
- Start
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Epaxal Junior in hepatitis A (HAV) (3 arms), sponsored by Berna Biotech AG. Started Nov 2006; status: completed.
02
Drugs
Epaxal Junior
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on ISRCTN91009479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91009479.